Closed System Transfer Devices Market Analysis

  • Report ID: 4090
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Closed System Transfer Devices Market Analysis

End-user (Hospitals & Clinics, Oncology Centers)

The global closed system transfer devices market is segmented and analyzed for demand and supply by end-use in hospitals & clinics, oncology centers, and others. Out of these, the hospitals & clinics segment is anticipated to hold the largest market share by the end of 2037. This can be attributed owing to the great financial power of hospitals to afford high-ranged CSTSs, the growing prevalence of cancer, and the requirement imposes some regulatory guidelines. According to the American Cancer Society, an estimated 1.9 million new cancer cases were diagnosed in the United States in 2021, with approximately 608,570 deaths from cancer. The acceptance of closed system transfer devices (CSTDs) in healthcare has increased significantly in recent years. Several factors have contributed to this trend, including increased awareness of the risks associated with exposure to hazardous drugs, regulatory requirements, and technological improvements oncology medical devices, and many more. The use of closed-system transfer devices in hospitals is also driven by regulatory requirements. Several regulatory agencies, such as the Occupational Safety and Health Administration (OSHA) and the National Institute for Occupational Safety and Health (NIOSH), have issued guidelines recommending the use of closed system transfer devices for hazardous drug handling in healthcare facilities.

Type (Membrane-to-Membrane, Needleless)

The global closed system transfer devices market is segmented and analyzed for demand and supply by type into membrane-to-membrane and needleless. Out of these, the membrane-to-membrane segment is anticipated to account for the largest market share by the end of 2037. The huge share and the growth of this segment can be attributed owing to the simplicity of operation and low risk of contamination associated with the double membrane containment system.

Our in-depth analysis of the global market includes the following segments:

        By Type

  • Membrane-to-Membrane

  • Needleless

        By Technology

  • Diaphragm based

  •  Compartmentalized

  • Filtration

  • Others

        By End User

  • Hospitals & Clinics

  •  Oncology Centers

  •  Others

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4090
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of closed system transfer devices is estimated at USD 1.14 billion.

The closed system transfer devices market size was valued at USD 1.01 billion in 2024 and is likely to cross USD 7.19 billion by 2037, expanding at more than 16.3% CAGR during the forecast period i.e., between 2025-2037. The increasing use of antineoplastics for the treatment of cancer will boost the market growth.

North America industry is poised to hold largest revenue share of 47% by 2037, due to higher use of antineoplastics for cancer treatment along with availability of advanced healthcare facilities in the region.

The major players in the market include Becton, Dickinson, and Company, B. Braun Melsungen AG, ICU Medical, Inc., Equashield, LLC, CODAN Medizinische Geräte GmbH & Co KG, Simplivia Healthcare Ltd., Corvida Medical, Inc., Caragen Ltd., Baxter International Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample